{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T03:56:28Z","timestamp":1767585388043,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cirug\u00eda Espa\u00f1ola (English Edition)"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.cireng.2021.10.008","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T08:37:08Z","timestamp":1636360628000},"page":"724-729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["CBCRisk model to determine the risk of contralateral breast cancer in sporadic breast cancer"],"prefix":"10.1016","volume":"99","author":[{"given":"Mar\u00eda","family":"Domingo Bret\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Allu\u00e9 Caba\u00f1uz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00e9stor","family":"Cast\u00e1n Villanueva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Dolores","family":"Arribas del Amo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismael","family":"Gil Romea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"G\u00fcemes S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cireng.2021.10.008_bib0005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/SLA.0000000000002309","article-title":"Indications for contralateral prophylactic mastectomy: a consensus statement using modified delphi methodology","volume":"267","author":"Wright","year":"2018","journal-title":"Ann Surg."},{"key":"10.1016\/j.cireng.2021.10.008_bib0010","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1245\/s10434-013-3116-1","article-title":"Increased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy: an analysis of the NSQIP database","volume":"20","author":"Osman","year":"2013","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.cireng.2021.10.008_bib0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.breast.2012.01.019","article-title":"Post-mastectomy pain syndrome: incidence and risks","volume":"21","author":"Alves Nogueira Fabro","year":"2012","journal-title":"Breast."},{"key":"10.1016\/j.cireng.2021.10.008_bib0020","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1245\/s10434-011-1917-7","article-title":"Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and personality traits","volume":"18","author":"Frost","year":"2011","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.cireng.2021.10.008_bib0025","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/jnci\/djq018","article-title":"Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients","volume":"102","author":"Bedrosian","year":"2010","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.cireng.2021.10.008_bib0030","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1200\/JCO.2007.12.3141","article-title":"Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment","volume":"25","author":"Tuttle","year":"2007","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.cireng.2021.10.008_bib0035","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejso.2011.12.014","article-title":"Increasing rates of contralateral prophylactic mastectomy - a trend made in USA?","volume":"38","author":"G\u00fcth","year":"2012","journal-title":"Eur J Surg Oncol."},{"key":"10.1016\/j.cireng.2021.10.008_bib0040","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials","volume":"365","author":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG)","year":"2005","journal-title":"Lancet."},{"key":"10.1016\/j.cireng.2021.10.008_bib0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10549-016-4039-x","article-title":"A model for individualized risk prediction of contralateral breast cancer","volume":"161","author":"Chowdhury","year":"2017","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.cireng.2021.10.008_bib0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10549-018-4763-5","article-title":"Validation of a personalized risk prediction model for contralateral breast cancer","volume":"170","author":"Chowdhury","year":"2018","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.cireng.2021.10.008_bib0055","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1245\/s10434-016-5443-5","article-title":"Contralateral Prophylactic Mastectomy (CPM) consensus statement from the American Society of Breast Surgeons: data on CPM outcomes and risks","volume":"23","author":"Boughey","year":"2016","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.cireng.2021.10.008_bib0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/SLA.0b013e3182125b26","article-title":"Occult malignancy in patients undergoing contralateral prophylactic mastectomy","volume":"254","author":"King","year":"2011","journal-title":"Ann Surg."},{"key":"10.1016\/j.cireng.2021.10.008_bib0065","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.ejca.2011.05.004","article-title":"Risk factors for metachronous contralateral breast cancer suggest two aetiological pathways","volume":"47","author":"Vichapat","year":"2011","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.cireng.2021.10.008_bib0070","article-title":"Contralateral risk-reducing mastectomy: review of risk factors and risk-reducing strategies","volume":"2015","author":"Basu","year":"2015","journal-title":"Int J Surg Oncol."}],"container-title":["Cirug\u00eda Espa\u00f1ola (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173507721002593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173507721002593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:53:24Z","timestamp":1761875604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173507721002593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2173507721002593"],"URL":"https:\/\/doi.org\/10.1016\/j.cireng.2021.10.008","relation":{},"ISSN":["2173-5077"],"issn-type":[{"type":"print","value":"2173-5077"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CBCRisk model to determine the risk of contralateral breast cancer in sporadic breast cancer","name":"articletitle","label":"Article Title"},{"value":"Cirug\u00eda Espa\u00f1ola (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cireng.2021.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ciresp.2020.11.007","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 AEC. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}